Roche Holding AG (RHHBY)
52.51
+0.26
(+0.50%)
USD |
OTCM |
Oct 05, 16:00
Roche Price : 52.51 for Oct. 5, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 05, 2026 | 52.25 | 52.77 | 51.95 | 52.51 | 1.032M |
| Oct 02, 2026 | 52.38 | 52.46 | 51.83 | 52.25 | 640963.0 |
| Oct 01, 2026 | 52.49 | 52.52 | 52.05 | 52.35 | 1.494M |
| Sep 30, 2026 | 52.60 | 52.66 | 51.81 | 51.88 | 1.245M |
| Sep 29, 2026 | 52.43 | 52.73 | 51.95 | 52.25 | 2.235M |
| Sep 28, 2026 | 53.35 | 53.62 | 53.08 | 53.37 | 2.794M |
| Sep 25, 2026 | 54.53 | 54.61 | 54.12 | 54.45 | 1.778M |
| Sep 24, 2026 | 54.68 | 55.36 | 54.67 | 54.80 | 1.011M |
| Sep 23, 2026 | 55.62 | 55.87 | 54.74 | 55.06 | 1.295M |
| Sep 22, 2026 | 54.99 | 55.77 | 54.68 | 55.66 | 1.748M |
| Sep 21, 2026 | 55.37 | 55.59 | 55.05 | 55.30 | 1.379M |
| Sep 18, 2026 | 54.63 | 54.66 | 54.00 | 54.15 | 1.092M |
| Sep 17, 2026 | 54.46 | 54.99 | 54.43 | 54.63 | 1.226M |
| Sep 16, 2026 | 55.29 | 55.64 | 54.89 | 55.15 | 1.029M |
| Sep 15, 2026 | 54.44 | 55.10 | 54.26 | 54.94 | 1.125M |
| Sep 14, 2026 | 55.86 | 55.99 | 54.61 | 54.80 | 1.666M |
| Sep 11, 2026 | 53.20 | 53.35 | 52.67 | 52.75 | 1.653M |
| Sep 10, 2026 | 52.99 | 53.53 | 52.90 | 53.19 | 1.489M |
| Sep 09, 2026 | 54.07 | 54.29 | 53.37 | 53.38 | 1.184M |
| Sep 08, 2026 | 54.24 | 54.42 | 53.87 | 54.07 | 1.301M |
| Sep 04, 2026 | 54.43 | 55.20 | 54.43 | 54.96 | 863861.0 |
| Sep 03, 2026 | 55.64 | 55.66 | 54.72 | 55.22 | 2.366M |
| Sep 02, 2026 | 53.94 | 54.28 | 53.59 | 53.83 | 3.493M |
| Sep 01, 2026 | 53.81 | 54.04 | 53.07 | 53.09 | 5.094M |
| Aug 31, 2026 | 54.85 | 54.85 | 53.36 | 53.70 | 6.501M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Novartis AG | 140.76 |
| AstraZeneca PLC | 158.58 |
| GSK Plc | 46.60 |
| Johnson & Johnson | 254.78 |
| Eli Lilly & Co. | 1157.35 |
Price Related Metrics
| PE Ratio | 21.72 |
| PS Ratio | 4.402 |
| PEG Ratio | 0.7289 |
| Price to Free Cash Flow | 20.65 |
| Earnings Yield | 4.60% |
| Market Cap | 289.89B |
| PEGY Ratio | 0.6632 |
| Operating PE Ratio | 14.36 |
| Normalized PE Ratio | 18.20 |